
Xencor Inc — Investor Relations & Filings
Xencor Inc. is a clinical-stage biopharmaceutical company that develops engineered monoclonal antibody and cytokine therapeutics. The company's proprietary XmAb® protein engineering platform is used to create novel drug candidates with enhanced functionality, stability, and extended half-life for the treatment of cancer and autoimmune diseases. This technology enables the development of various therapeutic modalities, including bispecific antibodies designed to engage multiple targets simultaneously. Xencor is advancing a broad pipeline of candidates, with numerous programs in clinical testing, and its technology is utilized in several medicines marketed by partners.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 10-Q - Xencor Inc (0001326732) (Filer) | 2026-05-06 | English | |
| 8-K - Xencor Inc (0001326732) (Filer) | 2026-05-05 | English | |
| DEF 14A - Xencor Inc (0001326732) (Filer) | 2026-04-27 | English | |
| 8-K - Xencor Inc (0001326732) (Filer) | 2026-04-27 | English | |
| SCHEDULE 13G - Xencor Inc (0001326732) (Subject) | 2026-03-31 | English | |
| SCHEDULE 13G/A - Xencor Inc (0001326732) (Subject) | 2026-03-27 | English |
Browse filings by year
18 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
11 filings
| |||||
| 41996178 | 10-Q - Xencor Inc (0001326732) (Filer) | 2026-05-06 | English | ||
| 41376711 | 8-K - Xencor Inc (0001326732) (Filer) | 2026-05-05 | English | ||
| 37614926 | DEF 14A - Xencor Inc (0001326732) (Filer) | 2026-04-27 | English | ||
| 37610403 | 8-K - Xencor Inc (0001326732) (Filer) | 2026-04-27 | English | ||
| 33094516 | SCHEDULE 13G - Xencor Inc (0001326732) (Subject) | 2026-03-31 | English | ||
| 33064529 | SCHEDULE 13G/A - Xencor Inc (0001326732) (Subject) | 2026-03-27 | English | ||
| 32890164 | S-3ASR - XENCOR INC (0001326732) (Filer) | 2026-02-25 | English | ||
| 32890165 | 10-K - XENCOR INC (0001326732) (Filer) | 2026-02-25 | English | ||
| 32890163 | 8-K - XENCOR INC (0001326732) (Filer) | 2026-02-25 | English | ||
| 28901042 | 4 Filing | 2026-01-26 | English | ||
| 28901066 | 8-K Filing | 2026-01-08 | English | ||
|
2025
4 filings
| |||||
| 11849927 | FORM 4 | 2025-12-23 | English | ||
| 11849928 | FORM 4 | 2025-12-23 | English | ||
| 11849929 | Regulatory Filings 2025 | 2025-12-19 | English | ||
| 11849930 | Regulatory Filings 2025 | 2025-12-19 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Beijing Kawin Technology Share-Holding Co., Ltd.
Biopharmaceutical firm specializing in viral infections, on…
|
688687 | CN | Manufacturing |
|
Beijing Konruns Pharmaceutical Co.,Ltd.
Develops and commercializes innovative surgical hemostasis …
|
603590 | CN | Manufacturing |
|
BEIJING LEADMAN BIOCHEMISTRY CO.,LTD.
Develops and manufactures in-vitro diagnostic reagents and …
|
300289 | CN | Manufacturing |
|
Beijing Luzhu Biotechnology Co., Ltd.
R&D and commercialization of innovative human vaccines and …
|
2480 | HK | Manufacturing |
|
Beijing Science Sun Pharmaceutical Co.,LTD.
Develops biochemical medicines for cardiovascular, immune, …
|
300485 | CN | Manufacturing |
|
Beijing SL Pharmaceutical Co., Ltd.
Develops and manufactures drugs for cardiovascular, oncolog…
|
002038 | CN | Manufacturing |
|
Beijing Strong Biotechnologies, Inc
Develops and manufactures IVD products, clinical chemistry …
|
300406 | CN | Manufacturing |
|
Beijing Tiantan Biological Products Corporation Limited
Researches and produces plasma-derived medicinal products a…
|
600161 | CN | Manufacturing |
|
Beijing Tong Ren Tang Chinese Medicine Company Limited
A manufacturer and retailer of traditional Chinese medicine…
|
3613 | HK | Manufacturing |
|
BEIJING TONG REN TANG CO., LTD
Researches, manufactures, and distributes Traditional Chine…
|
600085 | CN | Manufacturing |
Xencor Inc via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/32653/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=32653 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=32653 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=32653 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 32653}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Xencor Inc (id: 32653)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.